|
Thursday, June 17, 2004
|
| |
TRANSFORMING THE SCIENCE OF MIGRAINE
|
| |
Sponsored Symposium
By MSD
|
| |
Chairman: M. Ferrari,
Leiden, The Netherlands |
| 08:30 |
Opening Remarks
M. Ferrari, The Netherlands |
| 08:35 |
The Migraine Debate Continues:
Disease or Disorder
H.C. Diener, Germany |
| 08:50 |
New Evidence for Treatment
with Triptans
R. Cady, USA |
| 09:05 |
Cost-Effectiveness of
Oral Triptan Therapy in the Management of Acute Migraine
J. Belsey, UK |
| 09:20 |
Pharmacology of neurogenic
vasodilatation - new approaches in migraine research
R. Hargreaves, USA |
| 09:35 |
Panel Discussion |
| 09.55 |
Closing Remarks
M. Ferrari, The Netherlands |
| |
|
| 10:30-11:30 |
THE SECOND EDITION OF HEADACHE CLASSIFICATION
|
|
Chair:
J. Schoenen, Belguim |
|
New international diagnostic criteria for headache
J. Olesen, Denmark
|
|
Use of diagnostic criteria illustrated with case histories
J. Olesen, Denmark
|
|
|
| 11:30-12:30 |
GUIDELINES FOR MIGRAINE TREATMENT
A DEBATE BETWEEN USA AND EUROPE
|
|
Chair:
M.D. Ferrari, The Netherlands
|
American view
S. Silberstein, USA |
|
European view
H-C. Diener, Germany
|
|
Critique of American view
H-C. Diener, Germany
|
|
Critique of European view
S. Silberstein, USA
|
|
Discussion and other viewpoints
|
|
|
| 13:00–13:45 |
Lunch Seminars
|
|
Lunch Seminar 1
Differential diagnosis for migraine aura, TCIs, and simple partial
seizures; illustrated with case stories and videos
M.J.A. Láinez, Spain |
Lunch Seminar 2
Hemicrania continua, SUNCT and similar headaches
V. Limmroth, Germany |
Lunch Seminar 3
Non evidence-based therapy of migraine and cluster headache
J. Afra, Hungary |
|
|
| 14:00 – 15:30 |
TENSION-TYPE HEADACHE
|
| |
Chair:
M. Ashina, Denmark
M.A.M. Bomhof, The Netherlands |
|
Peripheral mechanism in tension type headache
R. Burstein, USA
|
|
Central mechanisms in tension type headache
L. Bendtsen, Denmark
|
|
Tension-type headache - Treatment strategies
J. Schoenen, Belgium
|
|
Future directions
M. Ashina, Denmark
|
|
General Discussion
|
| |
|
| 15:30-16:00 |
Platform Presentations |
|
Symptomatology, impact and treatment of 6000 headache attacks and episodes:
the pamina study
C. Woeber, Austria
|
|
Effect of low intensity acenocoumarol
on frequency and severity of migraine attacks: an open cross-over study
E.A. Wammes - van de Heijden, M. Smidt, C.C. Tijssen, A.R. van 't
Hoff, A.W. Lenderink, A.C.G. Egberts, The Netherlands |
|
Lamotrigine in the prevention of migraine aura
J. Pascual, Spain
|
|
|
| 16:30-17:30 |
Poster Presentations and discussion
|
|
|
| 17:30-19:00 |
NONRESPONSE TO TREATMENT
OF ACUTE MIGRAINE: HOW MUCH DO WE KNOW? |
| |
Symposium
Sponsored
by Almirall |
| |
Chairs: M.D. Ferrari,
The Netherlands
M.J.A. Lainez, Spain |
Is migraine a progressive
brain disease?
M.D. Ferrari, The Netherlands |
Defining nonresponse:
which endpoints are important?
M.J.A. Lainez, Spain |
Are patients getting
what they want from their acute migraine therapy?
H. Massiou, France |
A double-blind, randomized,
parallel-group trial of almotriptan 12.5 mg vs. placebo in migraine patients
who respond poorly to sumatriptan 50 mg
H.C. Diene, Germany |
| Discussion |
| |
